Optimal antithrombotic treatment during primary percutaneous coronary intervention?

Heart

Volumn 97, Issue 18, 2011, Pages 1459-1460

  Langrish, Jeremy P ^a   Fox, Keith A A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG;

BLEEDING; DISEASE ASSOCIATION; EDITORIAL; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME;

EID: 85027925554     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/Heartjnl-2011-300367     Document Type: Editorial

References (9)

1. Widimsky P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010;31:943-57.
2. Kushner FG, Hand M, Smith SCJr, et al. 2009 Focused apdates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120:2271-306.
3. Van de Werf F, Bax J, Betriu A, et al ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45.
4. Stone GW, Witzenbichler B, Guagliumi G, et al HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008;358:2218-30. (Pubitemid 351724451)
5. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006;355:2203-16. (Pubitemid 44791162)
6. Koutouzis M, Lagerqvist B, James S, et al. Unfractionated heparin administration in patients treated with bivalirudin during primary percutaneous coronary intervention is associated lower mortality and target lesion thrombosis: a report from the Swedish Coronaray Angiography and Angioplasty Registry (SCAAR). Heart 2011;97:1484-8.
7. Rao SV, Cohen MG, Kandzari DE, et al. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Coll Cardiol 2010;55:2187-95.
8. Fox KA, Eagle KA, Gore JM, et al. The global registry of acute coronary events, 1999 to 2009-GRACE. Heart 2010;96:1095-101.
9. Dangas GD, Caixeta A, Mehran R, et al. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction. Circulation 2011;123:1745-56.